Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

US Patent 8846675 · Granted Sep 30, 2014

Estimated economic value: $2,086,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleotide derivatives and methods of use thereof2025
Compounds and methods for the targeted degradation of androgen receptor2025
Compounds and methods for the enhanced degradation of targeted proteins2025
Nucleotide analogues and use thereof for nucleic acid sequencing and analysis pr2025
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2024
2-azaspiro[3.4]octane derivatives as M4 agonists2024
Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical comp2024
3′-O-modified nucleotide analogues with different cleavable linkers for attachin2024
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2024
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2024
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2024
2-azaspiro[3.4]octane derivatives as M4 agonists2023